SEK52.20
2.61% today
Stockholm, Apr 02, 05:29 pm CET
ISIN
SE0000163628
Symbol
EKTA B
Sector

Elekta AB Stock price

SEK52.20
-7.45 12.49% 1M
-18.85 26.53% 6M
-8.95 14.64% YTD
-30.60 36.96% 1Y
-25.14 32.51% 3Y
-28.10 34.99% 5Y
-25.30 32.65% 10Y
Stockholm, Closing price Wed, Apr 02 2025
-1.40 2.61%
ISIN
SE0000163628
Symbol
EKTA B
Sector

Key metrics

Market capitalization SEK20.48b
Enterprise Value SEK25.80b
P/E (TTM) P/E ratio 19.73
EV/FCF (TTM) EV/FCF 12.08
EV/Sales (TTM) EV/Sales 1.44
P/S ratio (TTM) P/S ratio 1.15
P/B ratio (TTM) P/B ratio 1.90
Dividend yield 4.48%
Last dividend (FY23) SEK2.40
Revenue growth (TTM) Revenue growth -1.85%
Revenue (TTM) Revenue SEK17.88b
EBIT (operating result TTM) EBIT SEK1.94b
Free Cash Flow (TTM) Free Cash Flow SEK2.14b
Cash position SEK3.58b
EPS (TTM) EPS SEK2.72
P/E forward 17.20
P/S forward 1.12
EV/Sales forward 1.42
Show more

Is Elekta AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Elekta AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Elekta AB forecast:

5x Buy
31%
6x Hold
38%
5x Sell
31%

Analyst Opinions

16 Analysts have issued a Elekta AB forecast:

Buy
31%
Hold
38%
Sell
31%

Financial data from Elekta AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jan '25
+/-
%
17,884 17,884
2% 2%
100%
- Direct Costs 11,392 11,392
0% 0%
64%
6,492 6,492
6% 6%
36%
- Selling and Administrative Expenses 2,266 2,266
1% 1%
13%
- Research and Development Expense 1,654 1,654
22% 22%
9%
2,572 2,572
20% 20%
14%
- Depreciation and Amortization 633 633
5% 5%
4%
EBIT (Operating Income) EBIT 1,939 1,939
26% 26%
11%
Net Profit 1,038 1,038
28% 28%
6%

In millions SEK.

Don't miss a Thing! We will send you all news about Elekta AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. Elekta operates through the following geographical segments: North and South America; Europe, Middle East and Africa; and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Jonas Bolander
Employees 4,641
Founded 1972
Website www.elekta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today